- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Sarilumab – November 2018
Sarilumab: Injection 200 mg in 1.14 mL pre-filled syringe, Injection 150 mg in 1.14 mL pre-filled sy
Last updated
1 March 2019